Austrian Health Authorities Approve VAZKEPA® (icosapent ethyl) for National Reimbursement to Reduce Risk of Cardiovascular Events in Eligible Patients -- -- Effective 1 April 2025, Austrian ...

Colorectal cancer, the second most common cause of cancer-related death, affects almost 2 million people worldwide every year ...

It wasn’t until late last year, 35 years into its history, that Ionis Pharmaceuticals e | To support the launch of Tryngolza, ...

Cholesterol levels are related to heart health, but how much do we really know about its impact on our overall health? Dive ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

Researchers from Osaka University find that tricaprin improves survival in patients with a novel heart disease, triglyceride ...

A new heart disease- cardiomyovasculopathy is a rare and fatal form of heart disease. During research, a natural component ...

FCS has no approved treatments in the US ... in which olezarsen was shown to reduce triglycerides by 49% after six months in patients with HTG and high cardiovascular risk when added to standard ...

Crestor (rosuvastatin) and Lipitor (atorvastatin) are the top medications for lowering blood levels of cholesterol and triglycerides. High cholesterol (and triglycerides) occurs when the fat in your ...

Nov. 21, 2024 — Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding ...

The American Diabetes Association recommends that mothers get tested for diabetes four to 12 weeks after birth and be referred to a specialist for treatment if diabetes is diagnosed. Increasing ...

If you have high blood pressure and a low pulse, your treatment options will depend on the cause of the condition and its severity. Healthcare providers will commonly treat this condition with ...